Patents by Inventor Ronald W. Raab

Ronald W. Raab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and reagents for diagnosing Sjögren's Syndrome
    Patent number: 10912830
    Abstract: The inventive subject matter relates to novel antibodies to lacritin splice variants, improved methods for detecting lacritin splice variants, and methods for diagnosing Sjögren's Syndrome.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: February 9, 2021
    Assignee: JAMES MADISON INNOVATIONS, INC.
    Inventors: Robert L McKown, Kyle Seifert, Ronald W Raab
  • NOVEL METHODS AND REAGENTS FOR DIAGNOSING SJÖGREN'S SYNDROME
    Publication number: 20180214545
    Abstract: The inventive subject matter relates to novel antibodies to lacritin splice variants, improved methods for detecting lacritin splice variants, and methods for diagnosing Sjögren's Syndrome.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 2, 2018
    Inventors: Robert L. McKown, Kyle Seifert, Ronald W. Raab
  • Antimicrobial Activity in Variants of Lacritin
    Publication number: 20090312252
    Abstract: The present invention provides recombinant proteins with antimicrobial activity and methods for treating animals including humans by administering the novel recombinant proteins. In particular, the invention provides methods for treating and/or preventing microbial diseases and infections using lacritin and homologs, fragments, modifications, and derivatives thereof.
    Type: Application
    Filed: September 13, 2007
    Publication date: December 17, 2009
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Robert L. McKown, Ronald W. Raab, Gordon W. Laurie
  • Recombinant antibodies for human therapy
    Publication number: 20020150580
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Application
    Filed: May 8, 2001
    Publication date: October 17, 2002
    Applicant: IDEC Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab
  • Recombinant antibodies for human therapy
    Patent number: 5756096
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignee: IDEC Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab
  • Recombinant antibodies for human therapy
    Patent number: 5750105
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 12, 1998
    Assignee: IDEC Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab
  • Recombinant antibodies for human therapy
    Patent number: 5693780
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 2, 1997
    Assignee: Idec Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab
  • Recombinant antibodies for human therapy
    Patent number: 5681722
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 28, 1997
    Assignee: IDEC Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab
  • Recombinant antibodies for human therapy
    Patent number: 5658570
    Abstract: Chimeric antibodies including an Old World monkey portion and a human portion, nucleic acid encoding such antibodies, Old World monkey monoclonal antibodies, and methods for their production and use.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: August 19, 1997
    Assignee: Idec Pharmaceuticals Corporation
    Inventors: Roland A. Newman, Nabil Hanna, Ronald W. Raab